Merit Medical Systems Inc. 2026年季度报告

☒QUARTERLY REPORT PURSUANT TO SECTION13 OR 15(d)OF THE SECURITIESEXCHANGE ACT OF 1934 OR TRANSITION REPORT PURSUANT TO SECTION13 OR 15(d)OF THE SECURITIESEXCHANGE ACT OF 1934 For the transition period fromto. MERIT MEDICAL SYSTEMS,INC.(Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) 1600 West Merit Parkway, South Jordan, Utah 84095(Address of principal executive offices, including zip code)Registrant’s telephone number, including area code:(801) 253-1600 Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d)of theSecurities Exchange Act of 1934 during the preceding 12months (or for such shorter period that the registrant wasrequired to file such reports) and (2)has been subject to filing requirements for the past 90days. Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to besubmitted pursuant to Rule405 of Regulation S-T during the preceding 12months (or for such shorter period that the Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, asmaller reporting company or an emerging growth company.See the definitions of “large accelerated filer,” Large AcceleratedFiler☒AcceleratedFiler☐Non-Accelerated Filer☐SmallerReportingCompany☐EmergingGrowthCompany☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transitionperiod for complying with any new or revised financial accounting standards provided pursuant to Section13(a)of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2 of the Exchange Act). Yes Indicate the number of shares outstanding of each of the Registrant’s classes of common stock, as of the latestpracticable date. 59,654,855Shares outstanding as of April 28, 2026 Common Stock, no par valueTitle or class TABLE OF CONTENTS PART I.FINANCIAL INFORMATIONItem 1.Financial Statements (Unaudited)Consolidated Balance SheetsConsolidated Statements of IncomeConsolidated Statements of Comprehensive IncomeConsolidated Statements of Stockholders’ EquityConsolidated Statements of Cash FlowsCondensed Notes to Consolidated Financial StatementsItem 2.Management’s Discussion and Analysis of Financial Condition and Results ofOperationsItem 3.Quantitative and Qualitative Disclosures About Market RiskItem 4.Controls and ProceduresPART II.OTHER INFORMATIONItem 1.Legal ProceedingsItem 1A.Risk FactorsItem5.Other informationItem 6.ExhibitsSIGNATURES PARTI- FINANCIAL INFORMATION MERIT MEDICAL SYSTEMS,INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS MERIT MEDICAL SYSTEMS,INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS MERIT MEDICAL SYSTEMS,INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF INCOME MERIT MEDICAL SYSTEMS,INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME MERIT MEDICAL SYSTEMS,INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF CASH FLOWS MERIT MEDICAL SYSTEMS,INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF CASH FLOWS CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from issuance of common stock$2,775$13,152Contingent payments related to acquisitions(2,142)(52) Payment of taxes related to an exchange of common stock(6,922)(6,145)Net cash, cash equivalents, and restricted cash (used in) provided by financingactivities(6,289)6,955Effect of exchange rates on cash, cash equivalents, and restricted cash(426)936 Net increase in cash, cash equivalents and restricted cash41,70018,828 CASH, CASH EQUIVALENTS AND RESTRICTED CASH:Beginning of period448,549378,767End of period$ 490,249$ 397,595 See condensed notes to consolidated financial statements. MERIT MEDICAL SYSTEMS,INC. AND SUBSIDIARIESCONDENSED NOTESTO CONSOLIDATED FINANCIAL STATEMENTS 1.Basis of Presentation and Other Items.The interim consolidated financial statements of MeritMedical Systems, Inc. ("Merit," "we" or "us") for the three-month periods ended March31,2026 and 2025are not audited. Our consolidated financial statements are prepared in accordance with the requirements forunaudited interim periods and, consequently, do not include all disclosures required to be made inconformity with accounting principles generally accepted in the United States of America. In the opinionofour management,the accompanying consolidated financial statements contain all adjustments,consisting of normal recurring accruals, necessary for a fair presentation of our financial position, resultsof operations and cash flows for the periods presented in conformity with GAAP. The results of operations On October 3, 2025, Martha G. Aronson became Merit’s new Chief Executive Officer and chief operatingdecision maker (“CODM”). Beginning in the first quarter of 2026, the CODM began managing Merit’soperations and allocating resources on a consolidated basis and evaluating pe